These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 15298963

  • 1. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
    Raju J, Patlolla JM, Swamy MV, Rao CV.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
    Patlolla JM, Zhang Y, Li Q, Steele VE, Rao CV.
    Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
    Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS.
    Cancer Res; 1993 Sep 15; 53(18):4182-8. PubMed ID: 8364913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
    Lasko CM, Bird RP.
    Cancer Epidemiol Biomarkers Prev; 1995 Jan 01; 4(1):49-55. PubMed ID: 7894324
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Catalpa seed oil rich in 9t,11t,13c-conjugated linolenic acid suppresses the development of colonic aberrant crypt foci induced by azoxymethane in rats.
    Suzuki R, Yasui Y, Kohno H, Miyamoto S, Hosokawa M, Miyashita K, Tanaka T.
    Oncol Rep; 2006 Nov 01; 16(5):989-96. PubMed ID: 17016582
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
    Wali RK, Stoiber D, Nguyen L, Hart J, Sitrin MD, Brasitus T, Bissonnette M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 01; 11(11):1316-21. PubMed ID: 12433708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 9trans,11trans conjugated linoleic acid inhibits the development of azoxymethane-induced colonic aberrant crypt foci in rats.
    Yasui Y, Suzuki R, Kohno H, Miyamoto S, Beppu F, Hosokawa M, Miyashita K, Tanaka T.
    Nutr Cancer; 2007 Nov 01; 59(1):82-91. PubMed ID: 17927506
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
    Chiampanichayakul S, Kataoka K, Arimochi H, Thumvijit S, Kuwahara T, Nakayama H, Vinitketkumnuen U, Ohnishi Y.
    J Med Invest; 2001 Feb 01; 48(1-2):88-96. PubMed ID: 11286022
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Egg yolk proteins suppress azoxymethane-induced aberrant crypt foci formation and cell proliferation in the colon of rats.
    Ishikawa S, Asano T, Takenoshita S, Nozawa Y, Arihara K, Itoh M.
    Nutr Res; 2009 Jan 01; 29(1):64-9. PubMed ID: 19185779
    [Abstract] [Full Text] [Related]

  • 20. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV.
    Cancer Res; 2000 Jan 15; 60(2):293-7. PubMed ID: 10667579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.